Index Performance
Overview
Description
The integration of artificial intelligence in personalized medicine is revolutionizing healthcare by enabling more precise, efficient, and patient-specific treatment strategies. One of the primary drivers of this theme is the explosion of big data in genomics and patient records, which AI algorithms can analyze to identify patterns and correlations that might otherwise go unnoticed. Additionally, advancements in machine learning and deep learning technologies are enabling more accurate predictive modeling and diagnostic tools. The need for cost-efficient healthcare solutions that provide better patient outcomes is another significant catalyst. Regulatory bodies are gradually embracing AI-driven technologies due to their potential to improve healthcare quality and reduce errors, further accelerating adoption. Lastly, the growing consumer demand for customized healthcare solutions is pushing medical professionals and healthcare facilities to adopt AI to stay competitive. - [[AI-driven Genomics]]: Leveraging AI to analyze genetic data for tailored treatment plans. - [[Predictive Analytics in Healthcare]]: Using AI for early disease detection and risk assessment. - [[AI-powered Diagnostic Tools]]: Development of AI-based systems for accurate and quick diagnosis. - [[AI in Drug Discovery]]: Utilizing AI to streamline the drug discovery and development process. - [[Patient-specific Treatment Planning]]: AI interventions in creating personalized medicine protocols. This index was generated with help from Thematic Analyst.
- Inception Date06/05/2024
- WeightingEqual
- # of holdings25
What's inside?
Holdings
All holdings as of September 6, 2024
Absci Corp. (ABSI) | 5.84% | $456.50M | -62.28% | -166.46% | 61.36 |
Adaptive Biotechnologies Corp. (ADPT) | 5.78% | $629.71M | -11.72% | 48.83% | 2.77 |
aTyr Pharma, Inc. (LIFE) | 5.53% | $142.50M | N/A | N/A | 81.55 |
2seventy Bio, Inc. (TSVT) | 5.19% | $226.59M | -75.12% | 42.80% | 5.92 |
IQVIA Holdings, Inc. (IQV) | 4.93% | $44.31B | 2.53% | 27.71% | 3.35 |
Medtronic Plc (MDT) | 4.87% | $115.28B | 2.77% | 59.53% | 3.75 |
Quest Diagnostics, Inc. (DGX) | 4.85% | $17.02B | 2.52% | 32.37% | 2.17 |
Laboratory Corp. of America Holdings (LH) | 4.78% | $18.76B | 6.17% | 26.83% | 1.83 |
Abbott Laboratories (ABT) | 4.75% | $198.10B | 4.00% | 51.12% | 4.66 |
GE Healthcare Technologies, Inc. (GEHC) | 4.71% | $38.86B | 0.46% | 41.23% | 2.23 |
Kura Oncology, Inc. (KURA) | 4.04% | $1.48B | N/A | N/A | N/A |
Exscientia Plc (EXAI) | 3.99% | $633.35M | 48.17% | -180.33% | 11.40 |
CDW Corp. (CDW) | 3.95% | $28.35B | -3.60% | 21.81% | 1.71 |
Nano-X Imaging Ltd. (NNOX) | 3.71% | $345.15M | 4.53% | -109.30% | 36.49 |
Certara, Inc. (CERT) | 3.66% | $1.83B | 3.17% | 43.20% | 6.36 |
AbCellera Biologics, Inc. (ABCL) | 3.61% | $704.25M | -27.18% | -419.42% | 7.49 |
Ever Fortune.AI Co., Ltd. (6841) | 3.38% | $263.34M | 470.78% | 50.65% | 49.39 |
Tenaya Therapeutics, Inc. (TNYA) | 3.25% | $182.23M | N/A | N/A | N/A |
Simulations Plus, Inc. (SLP) | 3.15% | $690.27M | 14.23% | 71.49% | 12.95 |
23andMe Holding Co. (ME) | 3.15% | $103.14M | -33.60% | 36.44% | 0.49 |
OptimizeRx Corp. (OPRX) | 3.13% | $138.15M | 36.14% | 56.51% | 2.45 |
Recursion Pharmaceuticals, Inc. (RXRX) | 2.93% | $1.63B | 30.86% | 9.14% | 28.81 |
Hims & Hers Health, Inc. (HIMS) | 2.70% | $2.85B | 51.82% | 68.16% | 4.24 |
Moderna, Inc. (MRNA) | 2.40% | $28.02B | -29.94% | 35.27% | 7.61 |
Renovaro, Inc. (ENOB) | 1.73% | $91.56M | N/A | N/A | N/A |